← Back to all trials
Not Yet Recruiting
NCT05755646
Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial
Conditions: Hand-Foot Syndrome, Breast Cancer
Sex: Female
Ages: 18 Years – N/A
Phase: NA
Enrollment: 36
Sponsor: University Hospital Tuebingen
Location: Germany
Summary
The present pilot study investigates the feasibility of a prospective larger confirmatory study on the efficacy of Dr. Hauschka Med Ice Plant Intensive Cream for the prevention of hand-foot syndrome in patients with breast carcinoma undergoing therapy with doxorubicin and / or docetaxel.
Eligibility Criteria
Inclusion Criteria:Breast cancer patientsTherapy with Doxorubicin and/or DocetaxelKarnofsky performance status scale > 80Informed consentExclusion Criteria:Patients with previous skin disease and/or polyneuropathyIntolerance or allergic reaction on at least one ingredient of Ice Plant Intensive CreamAlready receiving chemotherapyUsage of Ice Plant Intensive Cream before trialSevere physical or psychological illness due to which the patient is not able to participate in the studyLack of German language skills
Source: ClinicalTrials.gov (NCT05755646). StuddyBuddy aggregates publicly available trial information.
